Treatment_of_murine_transitional_cell_carcinoma_with_intralesional_interleukin_2_and_murine_interferon_gamma._The_antitumor_effect_of_intralesionally_administered_recombinant_interleukin-2,_alone_or_in_combination_with_recombinant_interferon_gamma_was_studied_in_murine_transitional_cell_carcinoma,_MBT2._In_the_initial_prophylactic_model_treatment_was_started_at_day_one_at_the_site_of_tumor_inoculation._Maximal_and_significant_reduction_in_tumor_volume_occurred_in_groups_receiving_4,000_units_of_recombinant_interleukin_2_and_10(7)_colony_forming_units_Bacillus_Calmette_Guerin_(p_less_than_0.00001_vs_saline_control)._In_the_same_experiment,_a_reduction_in_tumor_incidence_and_increase_in_survival_occurred_in_groups_receiving_4,000_units_of_recombinant_interleukin_2,_1,000_units_of_recombinant_interleukin_2_plus_2,000_units_of_recombinant_interferon_gamma,_as_well_as_10(7)_colony_forming_units_Bacillus_Calmette_Guerin_relative_to_saline_control_(p_less_than_0.005)._The_dose-response_effect_of_recombinant_interleukin_2_alone_was_also_tested_in_a_model_of_an_established_transitional_cell_carcinoma._Intralesional_injection_treatments_were_initiated_after_tumors_were_palpable._Reduction_in_tumor_volume_was_observed_in_the_group_receiving_8,000_units_of_recombinant_interleukin_2_(p_=_0.01_vs_saline_control),_but_no_significant_advantage_in_survival_was_noted.